IonQ (IONQ) to Release Earnings on Wednesday

Key Points

• IonQ is set to release its Q2 2025 earnings report on August 6th, with analysts forecasting an earnings per share of ($0.13) and revenue of $17.23 million.
• IonQ's recent financial results show a negative net margin of 753.20% with revenue declining 0.2% year-over-year, although it exceeded revenue estimates in its last quarter.
• Multiple analysts have adjusted IonQ's target price, with predictions ranging from $30.00 to $70.00, reflecting a general sentiment of a "Moderate Buy" for the stock.

IonQ (NYSE:IONQ - Get Free Report) will likely be posting its Q2 2025 quarterly earnings results after the market closes on Wednesday, August 6th. Analysts expect IonQ to post earnings of ($0.13) per share and revenue of $17.23 million for the quarter. IonQ has set its Q2 2025 guidance at EPS and its FY 2025 guidance at EPS.

IonQ (NYSE:IONQ - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The company reported ($0.14) EPS for the quarter, beating analysts' consensus estimates of ($0.28) by $0.14. IonQ had a negative return on equity of 63.35% and a negative net margin of 753.20%. The company had revenue of $7.57 million during the quarter, compared to analysts' expectations of $7.51 million. During the same period last year, the business posted ($0.19) earnings per share. The firm's revenue was down .2% compared to the same quarter last year. On average, analysts expect IonQ to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

IonQ Price Performance

IonQ stock traded down $1.73 during midday trading on Friday, reaching $38.14. The company's stock had a trading volume of 19,969,313 shares, compared to its average volume of 19,793,778. The stock's 50-day simple moving average is $41.81 and its 200-day simple moving average is $34.34. IonQ has a 52-week low of $6.22 and a 52-week high of $54.74. The stock has a market capitalization of $9.98 billion, a P/E ratio of -25.60 and a beta of 2.54.

Insiders Place Their Bets

In related news, Director Kathryn K. Chou sold 6,789 shares of IonQ stock in a transaction on Friday, July 11th. The stock was sold at an average price of $43.14, for a total transaction of $292,877.46. Following the completion of the transaction, the director directly owned 60,839 shares of the company's stock, valued at approximately $2,624,594.46. The trade was a 10.04% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CRO Rima Alameddine sold 45,000 shares of the firm's stock in a transaction on Monday, July 7th. The stock was sold at an average price of $46.18, for a total value of $2,078,100.00. Following the transaction, the executive directly owned 552,592 shares of the company's stock, valued at $25,518,698.56. The trade was a 7.53% decrease in their position. The disclosure for this sale can be found here. Insiders sold 9,191,850 shares of company stock valued at $360,519,930 over the last 90 days. 5.20% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On IonQ

Several hedge funds have recently made changes to their positions in the business. Focus Partners Wealth boosted its holdings in shares of IonQ by 30.3% during the first quarter. Focus Partners Wealth now owns 46,782 shares of the company's stock worth $1,032,000 after purchasing an additional 10,881 shares during the last quarter. Royal Bank of Canada boosted its holdings in shares of IonQ by 12.5% during the first quarter. Royal Bank of Canada now owns 134,176 shares of the company's stock worth $2,962,000 after purchasing an additional 14,898 shares during the last quarter. Amundi acquired a new stake in shares of IonQ during the first quarter worth $630,000. AQR Capital Management LLC boosted its holdings in shares of IonQ by 106.2% during the first quarter. AQR Capital Management LLC now owns 57,305 shares of the company's stock worth $1,265,000 after purchasing an additional 29,513 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in shares of IonQ by 24.1% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 450,031 shares of the company's stock worth $9,932,000 after purchasing an additional 87,428 shares during the last quarter. Institutional investors and hedge funds own 41.42% of the company's stock.

Analyst Ratings Changes

IONQ has been the topic of a number of research reports. Needham & Company LLC reissued a "buy" rating and issued a $50.00 price objective on shares of IonQ in a report on Wednesday, June 11th. Wolfe Research began coverage on IonQ in a research note on Wednesday. They issued a "peer perform" rating on the stock. Benchmark boosted their price target on shares of IonQ from $50.00 to $55.00 and gave the stock a "buy" rating in a research note on Monday, July 7th. Cantor Fitzgerald assumed coverage on IonQ in a report on Wednesday, July 2nd. They set an "overweight" rating and a $45.00 price target on the stock. Finally, Rosenblatt Securities started coverage on IonQ in a report on Tuesday. They issued a "buy" rating and a $70.00 price objective on the stock. Four research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $45.00.

IonQ Company Profile

IonQ, Inc engages in the development of general-purpose quantum computing systems in the United States. It sells access to quantum computers of various qubit capacities. The company makes access to its quantum computers through cloud platforms, such as Amazon Web Services (AWS) Amazon Braket, Microsoft's Azure Quantum, and Google's Cloud Marketplace, as well as through its cloud service.